Are intrauterine devices (IUDs) and subdermal birth controls, such as Nexplanon (etonogestrel), combined contraceptives or progesterone-only?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IUDs and Subdermal Birth Controls are Progestin-Only Contraceptives

Intrauterine devices (IUDs) and subdermal birth controls such as Nexplanon (etonogestrel) are progestin-only contraceptives, not combined contraceptives. 1

Types of Contraceptives

Progestin-Only Methods:

  • Intrauterine Devices (IUDs):

    • Levonorgestrel-releasing IUD (LNG-IUD): Contains only progestin (levonorgestrel) that is released locally within the uterine cavity 1, 2
    • Copper IUD (Cu-IUD): Non-hormonal method that does not contain any hormones 1, 3
  • Subdermal Implants:

    • Etonogestrel implant (Nexplanon): Contains only progestin (etonogestrel) 1, 4
  • Other Progestin-Only Methods:

    • Progestin-only pills (POPs) 1
    • Depot medroxyprogesterone acetate (DMPA) injections 1, 4

Combined Hormonal Contraceptives (CHCs):

  • Contain both estrogen and progestin 1, 5
  • Include:
    • Combined oral contraceptives (COCs) 1
    • Combined hormonal patch 1
    • Combined vaginal ring 1, 6

Mechanism of Action

Progestin-Only Methods (IUDs and Implants):

  • LNG-IUD works primarily through:

    • Local release of levonorgestrel within the endometrial cavity 2
    • Strong suppression of endometrial growth 2
    • Thickening of cervical mucus to inhibit sperm penetration 5
    • Minimal systemic absorption 3
  • Etonogestrel implant (Nexplanon) works through:

    • Inhibition of ovulation 5
    • Thickening of cervical mucus 5
    • Changes to the endometrium that prevent implantation 5

Clinical Considerations

Effectiveness:

  • Both IUDs and subdermal implants are highly effective with failure rates of less than 1% per year 1, 4
  • They are classified as long-acting reversible contraceptives (LARC) 4
  • Their effectiveness is not dependent on user compliance, unlike combined hormonal methods 3, 4

Safety Profile:

  • Progestin-only methods like IUDs and implants can be safely used in women with:
    • History of venous thromboembolism 3
    • Cardiovascular disease 1
    • Migraine with aura 1
    • Breastfeeding women 6
    • Smokers over age 35 6

Common Side Effects:

  • LNG-IUD may cause:

    • Reduced menstrual bleeding or amenorrhea in 35% of women after 2 years 3, 2
    • Initial irregular spotting in the first 2-3 months 2
  • Etonogestrel implant may cause:

    • Changes in bleeding patterns 4
    • Headache 6
    • Mood changes 4

Important Distinctions

  • Key difference: Combined contraceptives contain both estrogen and progestin, while IUDs and subdermal implants contain only progestin or no hormones (copper IUD) 1

  • The U.S. Medical Eligibility Criteria for Contraceptive Use clearly categorizes these methods separately, with different risk classifications for various medical conditions 1

  • Drug interactions differ between combined hormonal contraceptives and progestin-only methods like IUDs and implants 1

Clinical Applications

  • For patients with contraindications to estrogen (such as those with positive antiphospholipid antibodies), IUDs and implants are strongly recommended as safe alternatives 1

  • For adolescents and women who have never been pregnant, both IUDs and implants are safe and effective options with high continuation rates 1, 4

  • For women with medical conditions like SLE, IUDs and progestin implants are preferred over other hormonal contraceptives 1

Remember that while IUDs and subdermal implants are highly effective at preventing pregnancy, they do not protect against sexually transmitted infections 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.

Current problems in pediatric and adolescent health care, 2018

Research

Clinical relevance in present day hormonal contraception.

Hormone molecular biology and clinical investigation, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.